# US 2021/0330791 A1 · Multimodal therapy for cancer cell destruction

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0330791 A1
- Document ID: US20210330791A1
- Status: Published application
- Kind: A1
- Application number: 17/305,103
- Filed: 2021-06-30
- Published: 2021-10-28
- Earliest claimed: 2015-10-01
- Assignees: Southeast Missouri State University
- Applicants: Southeast Missouri State University
- Inventors: Santaneel Ghosh; Somesree GhoshMitra
- Web page: https://patentgrep.com/patent/US20210330791A1

## CPC

- A61K 41/0052: {Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy}
- A61K 33/24: Heavy metals; Compounds thereof
- A61K 33/242: Gold; Compounds thereof
- A61K 33/243: Platinum; Compounds thereof
- A61K 41/0028: {Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds}
- A61K 47/6923: {the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb}
- A61K 47/6933: {the polymer being obtained by reactions only involving carbon to carbon, e.g. poly(meth)acrylate, polystyrene, polyvinylpyrrolidone or polyvinylalcohol}
- A61K 47/6935: {the polymer being obtained otherwise than by reactions involving carbon to carbon unsaturated bonds, e.g. polyesters, polyamides or polyglycerol}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The field of the disclosure relates generally to cancer cell destruction and, more specifically, to cancer cell destruction by photo-magnetic irradiation mediated multimodal therapy using smart nanostructures.

## Claims

### Claim 1

A multimodal method of cancer cell destruction, the method comprising:
interacting at least one nanostructure with at least one cancer cell, wherein the at least one nanostructure comprises a cluster of nanoparticles, and wherein the cluster comprises at least one core-shell magnetic nanosphere (CSMNS) nanoparticle and at least one capped gold nanoparticle (AuNP);
applying optical irradiation induced temperature change to the at least one nanostructure;
simultaneously applying an oscillating magnetic field to the at least one nanostructure; and
inducing a coupled hyperthermia and oxidative stress to destroy the at least one cancer cell through the simultaneous optical irradiation and oscillating magnetic field application.

### Claim 2 (depends on 1)

The method of claim 1, wherein the simultaneous application of optical irradiation and oscillating magnetic field occur with an incubator-actuator device.

### Claim 3 (depends on 1)

The method of claim 1, wherein the oscillating magnetic field has an intensity of from about 0 Oe to about 150 Oe.

### Claim 4 (depends on 1)

The method of claim 1, wherein the oscillating magnetic field has a frequency of from about 0 kHz to about 1,000 kHz.

### Claim 5 (depends on 1)

The method of claim 1, wherein the at least one CSMNS nanoparticle has a diameter of from about 50 nm to about 400 nm.

### Claim 6 (depends on 1)

The method of claim 1, wherein the nanostructure comprises the at least one CSMNS nanoparticle at a concentration of from about 200 μg/ml to about 600 μg/ml.

### Claim 7 (depends on 1)

The method of claim 1, wherein the at least one CSMNS nanoparticle comprises a magnetic nanoparticle (MNP) core and a polymer shell.

### Claim 8 (depends on 7)

The method of claim 7, wherein the MNP core is selected from at least one of magnetite, ferric oxide, maghemite, gadolinium-doped cobalt ferrite, and combinations thereof.

### Claim 9 (depends on 7)

The method of claim 7, wherein the polymer shell comprises polyvinylpyrrolidone (PVP).

### Claim 10 (depends on 1)

The method of claim 1, wherein the nanostructure comprises the at least one capped AuNP at a concentration of from about 0.5 μg/ml to about 6 μg/ml.

### Claim 11 (depends on 1)

The method of claim 1, wherein the at least one capped AuNP is capped with a material comprising at least one of polyvinylpyrrolidone (PVP), polyethylene glycol (PEG), poly(N-i sopropylacrylamide)(PNIPAM), dextran, dimercaptosuccinic acid (DMSA) and combinations thereof.

### Claim 12

A nanostructure for cancer cell destruction, the nanostructure comprising:
a cluster of nanoparticles comprising:
at least one core-shell magnetic nanosphere (CSMNS) nanoparticle and at least one capped gold nanoparticle (AuNP).

### Claim 13 (depends on 12)

The nanostructure of claim 12, wherein the at least one CSMNS nanoparticle has a diameter of from about 50 nm to about 400 nm.

### Claim 14 (depends on 12)

The nanostructure of claim 12, wherein the nanostructure comprises the at least one CSMNS nanoparticle at a concentration of from about 200 μg/ml to about 600 μg/ml.

### Claim 15 (depends on 12)

The nanostructure of claim 12, wherein the at least one CSMNS nanoparticle comprises a magnetic nanoparticle (MNP) core.

### Claim 16 (depends on 15)

The nanostructure of claim 15, wherein the MNP core is selected from at least one of magnetite, ferric oxide, maghemite, gadolinium-doped cobalt ferrite, and combinations thereof.

### Claim 17 (depends on 12)

The nanostructure of claim 12, wherein the at least one CSMNS nanoparticle comprises a polymer shell.

### Claim 18 (depends on 17)

The nanostructure of claim 17, wherein the polymer shell comprises polyvinylpyrrolidone (PVP).

### Claim 19 (depends on 12)

The nanostructure of claim 12, wherein the nanostructure comprises the at least one capped AuNP at a concentration of from about 0.5 μg/ml to about 6 μg/ml.

### Claim 20 (depends on 12)

The nanostructure of claim 12, wherein the at least one capped AuNP is capped with a material comprising at least one of polyvinylpyrrolidone (PVP), polyethylene glycol (PEG), poly(N-isopropylacrylamide)(PNIPAM), dextran, dimercaptosuccinic acid (DMSA) and combinations thereof.
